Back to User profile » Dr Chris Compton
Papers published by Dr Chris Compton:
Economic Analysis of New Single-Inhaler Triple Therapies in Patients with COPD in the UK
Cai R, Martin AA, Ge Y, Risebrough NA, Haeussler K, Compton C, Halpin DM, Ismaila AS
International Journal of Chronic Obstructive Pulmonary Disease 2025, 20:2727-2743
Published Date: 7 August 2025
Treatment decisions: insights from people with asthma or COPD and their healthcare providers on disease and treatment decisions
Tal-Singer R, Román-Rodríguez M, McMullan I, Warner M, Compton C, Orlow J, Han MLK
Patient Preference and Adherence 2025, 19:1583-1591
Published Date: 6 June 2025
Sputum Microbiome, Potentially Pathogenic Organisms, and Clinical Outcomes in Japanese Patients with COPD and Moderate Airflow Limitation: The Prospective AERIS-J Study
Yatera K, Wang Z, Shibata Y, Ishikawa N, Homma T, Fukushima K, Hataji O, Inoue Y, Kawabata H, Miki K, Sato K, Tobino K, Yoshida M, Ishii T, Ito R, Kobayashi T, Kawamatsu S, Compton CH, Jones PW
International Journal of Chronic Obstructive Pulmonary Disease 2025, 20:1477-1492
Published Date: 14 May 2025
Perspectives on Treatment Decisions, Preferences, and Adherence and Long-Term Management in Asthma and COPD: A Qualitative Analysis of Patient, Caregiver, and Healthcare Provider Insights
Román-Rodríguez M, McMullan I, Warner M, Compton CH, Tal-Singer R, Orlow JM, Han MK
Patient Preference and Adherence 2024, 18:2295-2306
Published Date: 14 November 2024
Evaluation of Adherence and Persistence to Triple Therapy in Patients with COPD: A German Claims Data Study
Vogelmeier CF, Beeh KM, Schultze M, Kossack N, Richter LM, Claussen J, Compton C, Noorduyn SG, Ismaila AS, Requena G
International Journal of Chronic Obstructive Pulmonary Disease 2024, 19:1835-1848
Published Date: 9 August 2024
Characteristics of Users and New Initiators of Single- and Multiple-Inhaler Triple Therapy for Chronic Obstructive Pulmonary Disease in Germany
Beeh KM, Rothnie KJ, Claussen J, Hardtstock F, Knapp RK, Wilke T, Czira A, Compton C, Ismaila AS
International Journal of Chronic Obstructive Pulmonary Disease 2024, 19:945-956
Published Date: 17 April 2024
Risk Factors Associated with a First Exacerbation Among Patients with COPD Classified as GOLD A and B in Routine Clinical Practice in the UK
Rothnie KJ, Numbere B, Gelwicks S, Lu Y, Sharma R, Compton C, Ismaila AS, Quint JK
International Journal of Chronic Obstructive Pulmonary Disease 2023, 18:2673-2685
Published Date: 21 November 2023
Comparative Effectiveness of Umeclidinium/Vilanterol versus Indacaterol/Glycopyrronium on Moderate-to-Severe Exacerbations in Patients with Chronic Obstructive Pulmonary Disease in Clinical Practice in England
Requena G, Czira A, Banks V, Wood R, Tritton T, Castillo C, Yeap J, Wild R, Compton C, Rothnie KJ, Herth FJ, Quint JK, Ismaila AS
International Journal of Chronic Obstructive Pulmonary Disease 2023, 18:2039-2054
Published Date: 15 September 2023
Cost-Effectiveness of Single-Inhaler Triple Therapy (FF/UMEC/VI) versus Tiotropium Monotherapy in Patients with Symptomatic Moderate-to-Very Severe COPD in the UK
Kendall R, Martin AA, Shah D, Shukla S, Compton C, Ismaila AS
International Journal of Chronic Obstructive Pulmonary Disease 2023, 18:1815-1825
Published Date: 21 August 2023
Comparison of Rescue Medication Prescriptions in Patients with Chronic Obstructive Pulmonary Disease Receiving Umeclidinium/Vilanterol versus Tiotropium Bromide/Olodaterol in Routine Clinical Practice in England
Requena G, Czira A, Banks V, Wood R, Tritton T, Castillo CM, Yeap J, Wild R, Compton C, Rothnie KJ, Herth F, Quint JK, Ismaila AS
International Journal of Chronic Obstructive Pulmonary Disease 2023, 18:1431-1444
Published Date: 13 July 2023
Burden of Disease in Patients with Mild or Mild-to-Moderate Chronic Obstructive Pulmonary Disease (Global Initiative for Chronic Obstructive Lung Disease Group A or B): A Systematic Literature Review
Czira A, Purushotham S, Iheanacho I, Rothnie KJ, Compton C, Ismaila AS
International Journal of Chronic Obstructive Pulmonary Disease 2023, 18:719-731
Published Date: 29 April 2023
Comparative Effectiveness of Umeclidinium/Vilanterol versus Inhaled Corticosteroid/Long-Acting β2-Agonist in Patients with Chronic Obstructive Pulmonary Disease in a Primary Care Setting in England
Czira A, Requena G, Banks V, Wood R, Tritton T, Castillo CM, Yeap J, Wild R, Compton C, Rothnie KJ, Herth F, Quint JK, Ismaila AS
International Journal of Chronic Obstructive Pulmonary Disease 2023, 18:643-659
Published Date: 19 April 2023
Treatment Patterns, Healthcare Utilization and Clinical Outcomes of Patients with Chronic Obstructive Pulmonary Disease Initiating Single-Inhaler Long-Acting β2-Agonist/Long-Acting Muscarinic Antagonist Dual Therapy in Primary Care in England
Requena G, Banks V, Czira A, Wood R, Tritton T, Wild R, Compton C, Ismaila AS
International Journal of Chronic Obstructive Pulmonary Disease 2023, 18:231-245
Published Date: 5 March 2023
Cost-Effectiveness of Single- versus Multiple-Inhaler Triple Therapy in a UK COPD Population: The INTREPID Trial
Halpin DM, Kendall R, Shukla S, Martin A, Shah D, Midwinter D, Beeh KM, Kocks JWH, Jones PW, Compton C, Risebrough NA, Ismaila AS
International Journal of Chronic Obstructive Pulmonary Disease 2022, 17:2745-2755
Published Date: 25 October 2022
Comparative Adherence and Persistence of Single- and Multiple-Inhaler Triple Therapies Among Patients with Chronic Obstructive Pulmonary Disease in an English Real-World Primary Care Setting
Halpin DM, Rothnie KJ, Banks V, Czira A, Compton C, Wood R, Tritton T, Massey O, Wild R, Snowise N, Nikitin K, Sharma R, Ismaila AS, Vogelmeier CF
International Journal of Chronic Obstructive Pulmonary Disease 2022, 17:2417-2429
Published Date: 24 September 2022